Biobot Surgical

Singapore, Singapore · Founded 2007 · Privately Held (backing)

Developer of a robotic prostate biopsy and treatment system designed for improved clinical outcomes. Biobot Surgical is based in Singapore, Singapore and was founded in 2007. Its last reported valuation was $54.3 million in Mar 2024. It has raised $38.7 million.

Last reported valuation

$54.3M

Oct 2026

Priced at

—

Total raised

$38.7M

Last round

—

How much has Biobot Surgical raised?

$38.7Macross 0 recorded rounds

Free account

More of Biobot Surgical with a free account

·The complete investor list: 16 names
·Watch Biobot Surgical: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Biobot Surgical investors

16 investors are on record for Biobot Surgical, including ClavystBio, Andreas Handayanto, Ang Tiam and Astrid Hill Investment.

For fundraisers

Raising for a company like Biobot Surgical?

16 investors have backed Biobot Surgical.

See all 16 investors →

Frequently asked about Biobot Surgical

How much has Biobot Surgical raised?: Biobot Surgical has raised $38.7M in total across 0 recorded funding rounds.